Advances in Cancer Treatment by Targeting the Neddylation Pathway

被引：30
|
作者：
Gai, Wenbin [1 ,2 ]
Peng, Zhiqiang [3 ]
Liu, Cui Hua [4 ]
Zhang, Lingqiang [1 ,2 ,3 ,5 ]
Jiang, Hong [1 ,2 ]
机构：
[1] Qingdao Univ, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Sch Basic Med, Dept Physiol,Med Coll, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Basic Med, Med Coll, State Key Disciplines Physiol, Qingdao, Peoples R China
[3] Beijing Inst Lifeom, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China
[4] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China
[5] Peixian Peoples Hosp, Xuzhou, Jiangsu, Peoples R China
来源：
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金：
中国国家自然科学基金;
关键词：
developmental down-regulation protein 8 (NEDD8); neddylation; MLN4924; treatment; cancer;
D O I：
10.3389/fcell.2021.653882
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Developmental down-regulation protein 8 (NEDD8), expressed by neural progenitors, is a ubiquitin-like protein that conjugates to and regulates the biological function of its substrates. The main target of NEDD8 is cullin-RING E3 ligases. Upregulation of the neddylation pathway is closely associated with the progression of various tumors, and MLN4924, which inhibits NEDD8-activating enzyme (NAE), is a promising new antitumor compound for combination therapy. Here, we summarize the latest progress in anticancer strategies targeting the neddylation pathway and their combined applications, providing a theoretical reference for developing antitumor drugs and combination therapies.
引用
收藏
页数：10
相关论文
共 50 条
  • [21] Targeting the Hippo signalling pathway for cancer treatment
    Nakatani, Keisuke
    Maehama, Tomohiko
    Nishio, Miki
    Goto, Hiroki
    Kato, Wakako
    Omori, Hirofumi
    Miyachi, Yosuke
    Togashi, Hideru
    Shimono, Yohei
    Suzuki, Akira
    JOURNAL OF BIOCHEMISTRY, 2017, 161 (03): : 237 - 244
  • [22] Hyper-Activation of Neddylation Pathway in Bladder Cancer
    Souccar, Sami
    Wang, Beverly
    Charifa, Ahmad
    Zi, Xiaolin
    Yaacoub, Ramy
    Edwards, Robert
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 614 - 616
  • [23] Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
    Li, Lihui
    Wang, Mingsong
    Yu, Guangyang
    Chen, Ping
    Li, Hui
    Wei, Dongping
    Zhu, Ji
    Xie, Li
    Jia, Huixun
    Shi, Jieyi
    Li, Chunjie
    Yao, Wantong
    Wang, Yanchun
    Gao, Qiang
    Jeong, Lak Shin
    Lee, Hyuk Woo
    Yu, Jinha
    Hu, Fengqing
    Mei, Ju
    Wang, Ping
    Chu, Yiwei
    Qi, Hui
    Yang, Meng
    Dong, Ziming
    Sun, Yi
    Hoffman, Robert M.
    Jia, Lijun
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (06):
  • [24] Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer
    Powell, Reid T.
    Rinkenbaugh, Amanda L.
    Guo, Lei
    Cai, Shirong
    Shao, Jiansu
    Zhou, Xinhui
    Zhang, Xiaomei
    Jeter-Jones, Sabrina
    Fu, Chunxiao
    Qi, Yuan
    Hancock, Faiza Baameur
    White, Jason B.
    Stephan, Clifford
    Davies, Peter J.
    Moulder, Stacy
    Symmans, W. Fraser
    Chang, Jeffrey T.
    Piwnica-Worms, Helen
    NPJ BREAST CANCER, 2024, 10 (01)
  • [25] Advances in targeting the WNT/13-catenin signaling pathway in cancer
    Chatterjee, Avradip
    Paul, Sayan
    Bisht, Bharti
    Bhattacharya, Shelley
    Sivasubramaniam, Sudhakar
    Paul, Manash K.
    DRUG DISCOVERY TODAY, 2022, 27 (01) : 82 - 101
  • [26] Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
    Takebe, Naoko
    Dat Nguyen
    Yang, Sherry X.
    PHARMACOLOGY & THERAPEUTICS, 2014, 141 (02) : 140 - 149
  • [27] Targeting the estrogen pathway for the treatment and prevention of lung cancer
    Burns, Timothy F.
    Stabile, Laura P.
    LUNG CANCER MANAGEMENT, 2014, 3 (01) : 43 - 52
  • [28] Agents targeting the Hedgehog pathway for pancreatic cancer treatment
    Bisht, Savita
    Brossart, Peter
    Maitra, Anirban
    Feldmann, Georg
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (12) : 1387 - 1398
  • [29] Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
    Iannelli, Federica
    Lombardi, Rita
    Milone, Maria R.
    Pucci, Biagio
    De Rienzo, Simona
    Budillon, Alfredo
    Bruzzese, Francesca
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2018, 13 (02) : 184 - 200
  • [30] Targeting the programmed cell death pathway for cancer treatment
    Clarke, MF
    Qian, D
    Han, J
    Nunez, G
    Wicha, M
    CANCER GENE THERAPY, 1999, 6 (06) : S1 - S1
12345